**Chapter 8**

*Type 2 Diabetes - From Pathophysiology to Cyber Systems*

kidney by silencing metabolic pathways.

Vockley CM, Thakore PI, Crawford GE, Reddy TE, et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nature biotechnology.

Science translational medicine. 2012;4(121):121ra18-ra18.

[148] Hilton IB, D'ippolito AM,

[149] Morita S, Noguchi H, Horii T, Nakabayashi K, Kimura M, Okamura K, et al. Targeted DNA demethylation in vivo using dCas9–peptide repeat and scFv–TET1 catalytic domain fusions. Nature biotechnology.

[150] WareJoncas Z, Campbell JM, Martínez-Gálvez G, Gendron WA,

Barry MA, Harris PC, et al. Precision gene editing technology and applications in nephrology. Nature Reviews Nephrology.

2018;**14**(11):663-677

2015;**33**(5):510-517

2016;**34**(10):1060-1065

Sirtuin-1 function attenuates diabetic kidney injury. Kidney International.

[141] Leung A, Trac C, Jin W, Lanting L, Akbany A, Sætrom P, et al. Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circulation research.

[140] Jin W, Reddy MA, Chen Z, Putta S, Lanting L, Kato M, et al. Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells. Journal of Biological Chemistry. 2012;**287**(19):15672-15683

2018;**93**(6):1330-1343

2013;**113**(3):266-278

2015;**47**(1):8-12

[142] Pott S, Lieb JD. What are super-enhancers? Nature genetics.

[143] Das S, Senapati P, Chen Z,

[144] Putta S, Lanting L, Sun G, Lawson G, Kato M, Natarajan R. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. Journal of the American Society of Nephrology. 2012;**23**(3):458-469

[145] Zhong X, Chung ACK, Chen H-Y, Dong Y, Meng X, Li R, et al. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia. 2013;**56**(3):663-674

[146] Kölling M, Kaucsar T,

2017;**25**(1):165-180

Schauerte C, Hübner A, Dettling A, Park J-K, et al. Therapeutic miR-21 silencing ameliorates diabetic kidney disease in mice. Molecular Therapy.

[147] Chau BN, Xin C, Hartner J, Ren S, Castano AP, Linn G, et al. MicroRNA-21 promotes fibrosis of the

Reddy MA, Ganguly R, Lanting L, et al. Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells. Nature Communications. 2017;**8**(1):1467

**196**
